Literature DB >> 16877288

Causal inference in primary open angle glaucoma: specific discussion on intraocular pressure.

Hossein Bahrami1.   

Abstract

OBJECTIVES: As the first part of a comprehensive review of the concept of causal inference in epidemiology, this article explains how causal inference is established in epidemiology and applies these methods to evaluate the evidence in favor or against the causal association between intraocular pressure (IOP) and primary open angle glaucoma (POAG) as an example.
METHODS: After an introduction to causal inference in epidemiology and general guidelines for assessment of the causal relationship, the association between IOP and POAG will be evaluated in the context of these guidelines and the categories suggested by the Surgeon General's report.
RESULTS: The literature indicates a consistent strong association between IOP and POAG and there is no strong evidence against temporal precedence. The association is biologically plausible, coherent with scientific principles, and has noticeable biological gradient. However, it seems that IOP is not specific for POAG and vice versa.
CONCLUSION: Despite the absence of specificity, we conclude that the evidence is sufficient to infer a causal relationship between IOP and POAG. In sum, based on the literature and our current knowledge of glaucoma, currently most competing causes are not strong enough to confront the causal role of IOP.

Entities:  

Mesh:

Year:  2006        PMID: 16877288     DOI: 10.1080/09286580600681339

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  14 in total

1.  The Foundation in Evidence of Medical and Dental Telephone Consultations.

Authors:  Martina Albrecht; Florian Isenbeck; Jüürgen Kasper; Ingrid Mühlhauser; Anke Steckelberg
Journal:  Dtsch Arztebl Int       Date:  2016-06-06       Impact factor: 5.594

2.  Recent Patents on Emerging Therapeutics for the Treatment of Glaucoma, Age Related Macular Degeneration and Uveitis.

Authors:  Aswani Dutt Vadlapudi; Ashaben Patel; Kishore Cholkar; Ashim K Mitra
Journal:  Recent Pat Biomed Eng       Date:  2012-04-01

Review 3.  Discovery of novel inhibitors for the treatment of glaucoma.

Authors:  Kishore Cholkar; Hoang M Trinh; Dhananjay Pal; Ashim K Mitra
Journal:  Expert Opin Drug Discov       Date:  2015-01-09       Impact factor: 6.098

4.  Prostaglandin pathway gene therapy for sustained reduction of intraocular pressure.

Authors:  Román A Barraza; Jay W McLaren; Eric M Poeschla
Journal:  Mol Ther       Date:  2009-12-01       Impact factor: 11.454

Review 5.  Primary open-angle glaucoma.

Authors:  Young H Kwon; John H Fingert; Markus H Kuehn; Wallace L M Alward
Journal:  N Engl J Med       Date:  2009-03-12       Impact factor: 91.245

6.  Novel ocular antihypertensive compounds in clinical trials.

Authors:  June Chen; Stephen A Runyan; Michael R Robinson
Journal:  Clin Ophthalmol       Date:  2011-05-20

7.  Estimating three-dimensional outflow and pressure gradients within the human eye.

Authors:  David W Smith; Chang-Joon Lee; William Morgan; Bruce S Gardiner
Journal:  PLoS One       Date:  2019-04-09       Impact factor: 3.240

8.  Reduced Pulsatile Trabecular Meshwork Motion in Eyes With Primary Open Angle Glaucoma Using Phase-Sensitive Optical Coherence Tomography.

Authors:  Kai Gao; Shaozhen Song; Murray A Johnstone; Qinqin Zhang; Jingjiang Xu; Xiulan Zhang; Ruikang K Wang; Joanne C Wen
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-12-01       Impact factor: 4.799

9.  The heritability of glaucoma-related traits corneal hysteresis, central corneal thickness, intraocular pressure, and choroidal blood flow pulsatility.

Authors:  Ellen E Freeman; Marie-Hélène Roy-Gagnon; Denise Descovich; Hugues Massé; Mark R Lesk
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

10.  Combined Multi-Modal Assessment of Glaucomatous Damage With Electroretinography and Optical Coherence Tomography/Angiography.

Authors:  Khaldoon O Al-Nosairy; Gokulraj T Prabhakaran; Konstantinos Pappelis; Hagen Thieme; Michael B Hoffmann
Journal:  Transl Vis Sci Technol       Date:  2020-11-02       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.